共 45 条
[1]
Kuhlmann C(2022)Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose Lancet Lond Engl 399 625-626
[2]
Mayer CK(2022)Effectiveness of BNT162b2 vaccine against omicron variant in South Africa N Engl J Med 386 494-496
[3]
Claassen M(2020)Spread of SARS-CoV-2 in the icelandic population N Engl J Med 382 2302-2315
[4]
Collie S(2021)Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn Germany Nat Commun 12 1-10
[5]
Champion J(2021)Estimates and determinants of SARS-Cov-2 seroprevalence and infection fatality ratio using latent class analysis: the population-based Tirschenreuth study in the hardest-hit german county in spring 2020 Viruses. 13 1118-1296
[6]
Moultrie H(2021)Protocol of the cologne corona surveillance (CoCoS) study- a prospective population-based cohort study BMC Public Health 21 1295-1039
[7]
Bekker LG(2020)Protocol of a population-based prospective COVID-19 cohort study Munich, Germany (KoCo19) BMC Public Health 20 1036-429
[8]
Gray G(2020)Suppression of a SARS-CoV-2 outbreak in the italian municipality of vo Nature. 584 425-160
[9]
Gudbjartsson DF(2021)SARS-CoV-2 cumulative incidence and period seroprevalence: results from a statewide population-based serosurvey in California. Open forum Infect Dis 8 ofab379-e931
[10]
Helgason A(2021)Prevalence of SARS-CoV-2 antibodies in the Palestinian population: a primary health center-based cross-sectional study PLoS One 16 e0258255-1382